Theralase Technologies Inc.
TLT.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -25.14% | -9.54% | -21.82% | -0.94% | 13.11% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -25.14% | -9.54% | -21.82% | -0.94% | 13.11% |
| Cost of Revenue | -41.35% | -32.19% | -36.48% | -8.59% | -2.19% |
| Gross Profit | -12.39% | 10.33% | -8.99% | 6.27% | 29.10% |
| SG&A Expenses | 3.25% | 0.74% | 4.52% | 2.54% | 1.57% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.61% | -15.57% | -8.23% | -1.85% | -2.12% |
| Operating Income | 12.00% | 16.85% | 4.98% | 2.06% | 5.28% |
| Income Before Tax | 11.13% | 16.90% | 5.52% | 2.51% | 6.06% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 11.13% | 16.90% | 5.52% | 2.51% | 6.06% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.13% | 16.90% | 5.52% | 2.51% | 6.06% |
| EBIT | 12.00% | 16.85% | 4.98% | 2.06% | 5.28% |
| EBITDA | 12.15% | 17.33% | 4.96% | 1.71% | 5.04% |
| EPS Basic | 17.74% | 21.21% | 11.36% | 10.14% | 13.89% |
| Normalized Basic EPS | 18.18% | 21.95% | 10.98% | 10.47% | 14.44% |
| EPS Diluted | 17.74% | 21.21% | 11.36% | 10.14% | 13.89% |
| Normalized Diluted EPS | 18.18% | 21.95% | 10.98% | 10.47% | 14.44% |
| Average Basic Shares Outstanding | 7.41% | 5.60% | 5.80% | 8.78% | 9.03% |
| Average Diluted Shares Outstanding | 7.41% | 5.60% | 5.80% | 8.78% | 9.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |